Works matching IS 03125963 AND DT 2024 AND VI 63 AND IP 1
Results: 10
A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 1, p. 27, doi. 10.1007/s40262-023-01339-y
- By:
- Publication type:
- Article
Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 1, p. 1, doi. 10.1007/s40262-023-01332-5
- By:
- Publication type:
- Article
Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antifungal Agents: A Review.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 1, p. 13, doi. 10.1007/s40262-023-01327-2
- By:
- Publication type:
- Article
Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target Attainment.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 1, p. 121, doi. 10.1007/s40262-023-01325-4
- By:
- Publication type:
- Article
How to Dose Vancomycin in Overweight and Obese Patients with Varying Renal (Dys)function in the Novel Era of AUC 400–600 mg·h/L-Targeted Dosing.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 1, p. 79, doi. 10.1007/s40262-023-01324-5
- By:
- Publication type:
- Article
Development of a Generic Fetal Physiologically Based Pharmacokinetic Model and Prediction of Human Maternal and Fetal Organ Concentrations of Cefuroxime.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 1, p. 69, doi. 10.1007/s40262-023-01323-6
- By:
- Publication type:
- Article
Interplay of UDP-Glucuronosyltransferase and CYP2C8 for CYP2C8 Mediated Drug Oxidation and Its Impact on Drug–Drug Interaction Produced by Standardized CYP2C8 Inhibitors, Clopidogrel and Gemfibrozil.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 1, p. 43, doi. 10.1007/s40262-023-01322-7
- By:
- Publication type:
- Article
Population Pharmacokinetic/Pharmacodynamic Analysis of the Glucokinase Activator PB201 in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus: Facilitating the Clinical Development of PB201 in China.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 1, p. 93, doi. 10.1007/s40262-023-01321-8
- By:
- Publication type:
- Article
Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight Individuals.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 1, p. 109, doi. 10.1007/s40262-023-01320-9
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 1, p. 57, doi. 10.1007/s40262-023-01319-2
- By:
- Publication type:
- Article